(Q33327988)

25 July 2017

title

Gemcitabine in locally advanced and metastatic non-small cell lung cancer: the Central European phase II study (English)

1 reference

25 July 2017

M Pesek

9

0 references

Luboš Petruželka

object named as

L Petruzelka

7

0 references

Maciej Krzakowski

5

object named as

M Krzakowski

1 reference

25 July 2017

4

J Jassem

1 reference

25 July 2017

P Zatloukal

1

1 reference

25 July 2017

E Kanitz

2

1 reference

25 July 2017

P Magyar

3

1 reference

25 July 2017

M Pawlicki

6

1 reference

25 July 2017

L Chovan

8

1 reference

25 July 2017

C Janko

10

1 reference

25 July 2017

K Krejcy

11

1 reference

25 July 2017

language of work or name

1 reference

1 December 1998

1 reference

25 July 2017

1 reference

25 July 2017

volume

22

1 reference

25 July 2017

issue

3

1 reference

25 July 2017

page(s)

243-250

1 reference

Patterns of cigarette sales and lung cancer mortality in some central and eastern European countries, 1960-1989.

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900082-8

7 January 2021

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900082-8

7 January 2021

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900082-8

7 January 2021

Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900082-8

7 January 2021

Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900082-8

7 January 2021

Single-agent gemcitabine versus cisplatin-etoposide: early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900082-8

7 January 2021

Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900082-8

7 January 2021

10.1016/S0169-5002(98)00082-8

Identifiers

DOI

1 reference

25 July 2017

1 reference